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Summary.-Two naturally occurring cytotoxic cell populations have been identified
in the peritoneal cavity of mice inoculated with C.parvum (CP), and are distinguish-
able on the basis of target-cell reactivity and intrinsic properties. The first effector
cell was non-adherent to nylon wool and glass and non-phagocytic. These cells were
selectively cytotoxic to the NK-sensitive target cell line K562, and present in the
peritoneal cavity of mice 2 days after treatment with 700 jig of CP. The second cyto-
toxic effector cell was adherent to nylon wool and glass, and killed EL4 lymphoma
cells derived from in vivo tumour transplants; these target cells are susceptible to
phagocytic cell killing, but not NK-cell cytotoxicity in short-term (4h) assays. The
adherent cytotoxic population of effector cells was present 4 days after inoculation
of CP.
In vivo studies showed that CP injected i.p. induced resistance to i.p. challenge with
lymphoma EL4 cells, but no resistance was evident when the challenge dose was
administered s.c. Adoptive-transfer studies showed that the effector cell type res-
ponsible for inhibiting tumour growth was nylon-wool adherent, probably CP-
activated macrophages.
IMMUNOSTIMULANTS such as Bacillus
Calmette Guerin (BCG) and Corynebac-
teriurn parvum (CP) have been found to
enhance non-specific anti-tumour cyto-
toxicity, and in particular NK cells (Wolfe
et al., 1976; Henney et al., 1978; Ojo, 1979;
Gidlund et al., 1978; Oehler et al., 1978).
Experimental evidence from these studies
supports the concept of indirect stimula-
tion of cytotoxic cells via interferon induc-
tion, which itself effectively stimulates
rodent (Senik et al., 1979; Djeu et al.,
1979a,b) and human (Trinchieri & Santoli,
1978; Einhorn et al., 1978; Moore &
Potter, 1980) natural killer (NK) cells, and
in vivo its production is under genetic
control (Kiessling & Wigzell, 1979). Im-
munostimulants such as BCG and CP have
also been shown to be effective in pro-
moting macrophage activity (Milas &
Scott, 1978; Baldwin & Pimm, 1978) and
to enhance resistance to tumour trans-
plantation (Henney et al., 1978; Ojo,
1979). Potentiation of the non-specific
cytotoxicity by CP has recently been
shown to be dependent on the dose and
strain of the organism (Flexman &
Shellam, 1980).
In the present study, CP treatment of
mice was shown to activate two popula-
tions of cytotoxic effector cells, distin-
guishable by their reactivity to targets of
known susceptibility to cytolysis by NK
or adherent phagocytic cells. In addition,
experiments were performed to investigate
the relevance of both cell types in con-
troling the in vivo growth of a transplant-
able murine lymphoma. Beside NK cells
and macrophages, there appears to be an
effector cell which may be related to NK
cells, but differs from NK in several basic
properties, and has been termed the
natural cytotoxic (NC) cell (Stutman et al.,
1978; Paige et al., 1978). Whereas NC cellsC. PARVUM STIMULATION OF CYTOTOXICITY
lyse solid tumour targets in 18-24h cyto-
toxicity tests, NK cells lyse lymphoma
target cells in short-term (4h) assays.
MATERIALS AND METHODS
Animals-.Healthy C57BL mice aged 6-8
weeks were obtained from our inbred colony
at the University of Sheffield and used in all
experiments.
Tumour target cells.-The C57BL T-lymph-
oma line EL4 was kindly supplied by Dr E.
Purves (St Mary's Hospital Medical School,
London) and maintained by weekly trans-
plantation of ascites cells into the peritoneal
cavity of the male C57BL mice. The erythro-
leukaemic cell line K562 was obtained as a
gift from Dr M. Moore (Paterson Labora-
tories, Manchester) and cultured in vitro in
RPMI 1640 supplemented with antibiotics
and 10% foetal calf serum (FCS).
Preparation of tumour cells.-EL4 lymph-
oma cells were harvested from the peritoneal
cavity ofC57BL mice in Medium 199, washed
x 3 and resuspended in M199 to the concen-
tration required. K562 erythroleukaemic cells
were harvested from in vitro cultures, and
similarly washed x 3 and resuspended in
M199.
Preparation of effector cells-.Normal and
C. parvum-stimulated peritoneal cells were
harvested from groups of mice at various
times after inoculation with M199 or 700 fig
of CP. Mice were killed, the peritoneal cavity
washed with 20 ml of M199 and the cells
sedimented by 120 g for 5 min. These were
then washed x 3 and resuspended to the
required concentration in M199.
Immunostimulatingagent.-Corynebacterium
parvum (CP) was obtained from Wellcome
Reagents Ltd, Hither Green, London, as a
formalin-killed preparation (ULOI; pre-
served in 0-01% thiomersal) and dialysed
against PBS before use, to remove toxic
substances.
Nylon-wool column fractionation.-This
method is described elsewhere (Julius et al.,
1973; Rees et al., 1975). Briefly, 0-5 gm of
nylon fibre was packed in a 5ml plastic
syringe and saturated with M199 containing
5 FCS, for 30 min before loading with
2-5 x 107 effector cells. The column was then
incubated in a humidified atmosphere in 5%
C02/95% air at 37°C for 40 min, and medium
run through the column at a constant rate to
obtain an eluted cell population. Column-
36
retained cells were recovered bygentle teasing
of the nylon fibres in M199.
Glass adherence.-One x 107 effector cells
suspended in M199 were incubated on glass
Petri dishes at 370C in a humidified atmos-
phere of 5% C02/95% air for 2 h. Non-
adherent cells were removed by vigorous
washing with M199 and adherent cells re-
covered by mechanical scraping. The cells
were then washed x3 and resuspended in
M199.
Carbonyl iron treatment.-Four mg of
carbonyl iron was added to 107 effector cells
in 1 ml of M199, and the mixture incubated
at 37°C for 30 min. Carbonyl iron was sedi-
mented on a magnet for 10 min at 40C, the
supernatant removed and the sedimentation
repeated. The recovered cells were washed
and adjusted to 5 x 107/ml in M199 and used
in experiments.
Preparation and use of anti-Thy 1:2 anti-
serum.-Anti-Thy 1:2 serum was prepared
by immunization ofAKR mice with 3 weekly
injections of 107 CBA thymocytes. The anti-
serum was collected one week after the 3rd
immunization, and was shown to demonstrate
selective complement dependent cytotoxicity
for thymocytes from CBA and C57BL mice,
but not AKR mice. This serum has also been
shown to specifically abolish antitumour
T-cell reactivity towards C57BL murine
sarcomas (Kadhim & Rees, unpublished).
Anti-Thy 1:2 treatment of effector cells was
performed as follows: 107 peritoneal cells
were treated with an appropriate dilution of
AKR anti-Thy 1:2 antiserum for 45 min at
4°C, centrifuged, and the supernatant re-
moved; the cells were then incubated with
guinea-pig complement for a further 30 min
at 37°C, after which the remaining effector
cells were washed x 3 in M199 before use.
Chromium-51 release assay.-Target cells
(106 cells/ml) were labelled with 100uCi
sodium chromate (Radio Chemical Centre,
Amersham, Bucks) and incubated for 1 h at
37°C. The cells were then washed and re-
suspended in M199, and reincubated for a
further hour. Following a second washing
( x 3), the targets were resuspended in M199
and adjusted to 105 cells/ml. Target cells
(0.1 ml) were mixed and incubated with
effector cells (0.1 ml) in round-bottomed
plastic microtest plates (NUNC-U-bottomed
plates, Gibco Biocult, Paisley, Scotland). The
E:T ratios ranged from 100:1 to 1:1. The
plates were then incubated in a humidified
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atmosphere in 5% C02 in air at 37'C for 4 h,
after which the plates were centrifuged at
200 g for 5 min and 0-I ml of supernatant
removed to another well. The plates were
then allowed to dry, sealed with parafilm and
the individual wells counted in a gamma
spectrophotometer. The per cent 51Cr release
was calculated, following background sub-
traction, according to the formula:
% 5lCr release= (1/2 supernatant) x 2
(1/2 supernatant) +
(cells+1/2 supernatant)
The per cent cytoxicity was calculated by
subtracting the % spontaneouS 51Cr release
from targets incubated in medium alone
(usually 5-10%) from the per cent 51Cr
release ofthe test.
Adoptive transfer and direct-challenge ex-
periments.-Peritoneal cells from normal and
CP-stimulated mice were collected, washed
and adjusted to the required concentration.
Equal volumes of effector cells and target
cells were mixed, and 0-2 ml injected s.e. into
groups of mice. The E: T ratio ranged from
1000: I to 1: 1; the target cells (lymphoma-
EL4) were injected at 103 cells/mouse, repre-
senting an inoculum of 10-20 TD50 for this
tumour.
Mice pre-treated with CP were challenged
s.c. or i.p. with 103 lymphoma cells and the
development of tuinours monitored over a
30-dayperiod.
Giemsastaining.-Morphological identifica-
tion of cytocentrifuged cell smears was per-
formed. Slide preparations were air dried,
fixed in methanol, and stained with 10%
Giemsa for 10 min.
RESULTS
In vitro cytotoxicity by C. parvum-stimu-
latedeffector cells
Effector cells were harvested from the
peritoneal cavity (PEC) of mice at differ-
ent times after i.p. injection of 700 .ug of
CP, and assayed for cytotoxicity against
K562 or EL4 targets in a 4h isotope-
release assay. The results given in the
Figure show the susceptibility of K562
and EL4 cells to CP-stimulated peritoneal
effectors. A difference was found in the
susceptibility of K562 and EL4 to PEC
harvested on Days 2, 39 4 and 7 after CP
W-4.
FIGURE.-Time course ofreactivity ofnylon-
wool column-eluted C. parvum-stimulated
effector cells (0), and nylon-wool column-
retained effector cells to lymphoma EL4
targets (0). Peritoneal cells were harvested
from groups of 3 mice, and pooled for
fractionation.
stimulation. The peak response to leuk-
aemic K562 targets was seen onDay 2 and
significant activity was also demonstrated
on Days 3 and 4 (Figure). Consistent cyto-
toxicity to EL4 target cells could not be
demonstrated on Day 2 (Tables 1, 11 &
111), but significant killing was apparent
on Days 3 and 4 (not Day 7) after in-
jection.
Experiments were performed to com-
TABLEI.-Cytotoxicityofadherentand non-
adherent C. parvum-stimulated mouse
peritoneal cells
% Cytotoxicity to target
cellsl
A
K562 EL4
(
Exp. Exp. Exp. Exp.
1 2 1 2
Effector cellst:CP
stimulated mouse
PEC
Day 2
Nylon-wool column-
eluted 21***
retained 7
Unfractionated 23***
Glass adherent 4
non-adherent 17*
Unfractionated 23***
Day 4
Nylon-wool column-
eluted 2
retained 2
Unfractionated I
Glass adherent I
non-adherent 0
Unfractionated 3
30***
0
40***
4
II**
13**
8
2
3
0
0
1
5
5
1
1
22**
13*
76***
10
II*
4
31**
11*
30***
22**
13*
t E:T ratio of 50: 1.
I Significant cytotoxicity from t
**P <0-01; ***P < 0.001.
test: *p < 0-05;C. PARVUM STIMULATION OF CYTOTOXICITY
pare the cytotoxic potential of CP-
stimulated PEC, harvested 2 or 4 days
after inoculation for both cell targets.
PEC were fractionated on nylon-wool
columns, and the column-eluted and re-
tained cells were tested for cytotoxicity
towards K562 and EL4 target cells. Simi-
larly, glass-adherent and non-adherent
effector cells were assayed for cytotoxicity,
and the combined results of these studies
are shown in Table I. The cytotoxicity of
PEC harvested 2 days after CP stimula-
tion to K562 targets was found preferenti-
ally in the nylon-wool-eluted and glass
non-adherent fractions which displayed
no apparent reactivity against EL4
lymphoma cells. In contrast, mouse PEC
harvested 4 days after CP inoculation
demonstrated preferential lysis of lymph-
oma EL4 cells, andmostofthecytotoxicity
was recovered from the nylon-wool-re-
tained and glass-adherent fractions (Table
I), though in one of two experiments,
glass non-adherent effectors gave signifi-
cant cytotoxicity to EL4 targets. These
results show that effectors are non-
adherent to glass and nylon wool, select-
ively cytotoxic to K562 targets, whereas
cells adherent to glass and nylon wool are
reactive to EL4 targets. Further evidence
for 2 populations of effector cells in CP-
stimulated PEC were found in studies of
TABLE II. Cytotoxicity of C
stimulated PECfallowing rem
1: 2 + lymphocytes and phag
% Cytotoxici
cells
K562
Effector elit Exp. Exp.
(motuse PEC) 1 2
Day 2
Anti-Thly 1: 2+ C
Carbon.yl iron
Untreated
Day 4
Anti-Thy 1: 2 +C
Carbonyl iron
Untreated
20** 12*
25** 12*
25** 15**
18*
1
14**
t E:T ratio of 50:1.
Significant (ytotoxicity from t te
**P < 0-01; ***1' < 0)01.
,. parvum-
aoval of Thy
rocytic cells
ty to target
I;
cell sensitivity to treatment with anti-Thy
1: 2+ complement, and carbonyl iron;
these results are shown in Table II. Thus,
cells harvested 2 days after PEC stimula-
tion and reactive to K562 targets, were not
affected by anti-Thy 1:2 + complement
treatment, or carbonyl iron treatment. In
contrast, cytotoxicity to both K562 and
EL4 targets mediated by stimulated PEC
harvested 4 days after (CP) inoculation,
was removed by carbonyl-iron treatment
but was unaffected by treatment with
anti-Thy 1: 2+ complement (Table II).
These results suggest that the effector cells
present 2 days after CP stimulation, and
mediating cytotoxicity to K562 are most
probably NK cells, whereas the cells
reactive to EL4 targets display the pro-
perties ofmacrophages.
To eliminate the possible involvement
of polymorphonuclear leucocytes in cyto-
toxicity to K562 and EL4 targets, effector
cells from 2 and 4 day CP-stimulated
mouse PEC were fractionated on Ficoll-
Triosil to yield an interface fraction
mainly of mononuclear cells, and a pellet
containing 65-75oo polymorphonuclear
leucocytes. When these cell fractions were
assayed for cytotoxicity, the observed
killing of both targets resided in the inter-
face fraction; the polymorphonuclear
leucocyte-enriched fraction failed to show
any significant cytotoxicity (Table III).
Enrichment of cytotoxicity was found
TABLE III.-Lack of correlation between
polymorphonuclear leucocyte content and
cytotoxicity of CP-stimulated PEC
EL4 Ficoll-Triosil % Cytotoxicity
fraction:effector to target cells$
Exp. Exp. cellst °~ PMIN -
1 2 (mouse PEC) cells K562 EL4
Day 2)
5 1 Tnterface 11 24** 9*
-4 -3 Pellet 72 3 3
7 0 Unfractionated( 38 22** 12**
Day 4
l0* 13** Interface 10 20** 36***
-2 1 Pellet 67 2 -4
10* 21*** Unfractionated 28 16** 24**
t E:T ratio of 50:1.
?st: *P < 0 05; + Significant cytotoxicity from t test: * P < 0 05;
**P < 0-01; ***P < 0-001.
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in many ofthe separations and treatments
performed. Failure to demonstrate an
increase in cytotoxicity may relate to a
loss of some of the effector cells during
treatment. For example, murine NK cells
have been shown to express Thy- I antigen,
and it is conceivable that some anti K562
effectors may have been destroyed by
exposure to anti-Thy 1: 2 +complement
(Koo et al., 1980).
In vivo resistance to tumour transplantation
Groups of mice were injected i.p. with
100 ug and 700 ,ug of CP, and 4 days later
challenged s.c. or i.p. with 103 EL4 cells.
The incidence of tumours developing in
the mice 30 days after inoculation is
shown in Table IV. Ascites tumours de-
veloped in all control mice during the
observation period (Table IV), and prior
administration of CP by the i.p. route
induced resistance to EL4 cells trans-
planted i.p. In contrast, no resistance was
found in mice given CP by the i.p. route,
and challenged s.c. (2 separate experi-
ments) (Table IV).
TABLE IV.-C. parvum-induced resistance
to transplantation of lymphoma EL4 cells
Mice treated i.p. Incidence of tumours
4 days prior to Route of 30 days after challenge
tumour challenge tumour ,_A_
(pg CP) challenget Exp. 1 Exp. 2
700 i.p. 0/4t 0/4
100 i.p. 0/4 0/4
i.p. 4/4 4/4
700 s.c. 4/4 4/4
100 s.c. 3/4 4/4
s.c. 4/4 4/4
t With 103 viable lymphoma cells in 0-2 ml.
t Mice with tumours
Mice injected
The tumour resistance induced by prior
inoculation with CP was further investi-
gated in adoptive-transfer (WINN) assays.
PEC were harvested at 2, 4 and 7 days
after i.p. inoculation of mice with 700 ,tg
of CP were mixed with 103 viable lymph-
oma EL4 cells at PEC:tumour cell ratios
of 1: 1, 10: 1, 100:1 or 1000: 1, and each
mixture inoculated s.c. into a group of
TABLE V.-Adoptive transfer of Mouse
PEC 2, 4 and 7 days after CP injection
Incidence of tumourst
Time after CP injection
(days)
E:T ratio 2 4 7
1:1 6/8t 5/8 8/8
10:1 6/8 3/8* 8/8
100:1 6/8 1/8 8/8
1000:1 5/8 1/8 4/8**
0:1 7/8 8/8 8/8
t Mice with tumours/mice inoculated 30 days
after 103 viable lymphoma cells in 0-2 ml were
inoculated per mouse.
*p <00}t test.
mice. The incidence of tumours in these
animals is shown in Table V. Control mice
injected s.c. with 103 EL4 lymphoma cells
alone developed progressive lymphomas,
whereas injection ofPEC harvested 4 days
after CP, in admixture with EL4 cells,
caused a significantreductioninlymphoma
incidence at E: T ratios of 1000: 1, 100:1
and 10:1 (Table V). In contrast, PEC
harvested 2 days after CP failed to inhibit
EL4 lymphoma cells growth, and transfer
of PEC harvested 7 days after CP was
only effective in reducing the tumour
incidence and size (P<0-01) at a 1000:1
ratio. The finding that adoptive transfer
of only PEC harvested 4 days after CP
inoculation prevented the development of
EL4 lymphomas in vivo agrees with the
results from the cytotoxicity tests. PEC
from normal C57BL mice failed to influ-
ence the growth of EL4 cells in adoptive-
transfer experiments (results not shown).
To determine further which cell fraction
was effective inpreventing EL4 lymphoma
growth, PEC were harvested from mice
4 days after inoculation with 700 ,ug of
CP and the cells fractionated into nylon-
wool-elutedandnylon-wool-retained popu-
lations. These fractions were separately
mixed with 103 lymphoma EL4 tumour
cells at E: T ratios of I: 1, 10: 1, 100:1 and
1000: 1, and the mixtures inoculated s.c.
into groups of mice. The incidence of
tumours in these animals is shown in
Table VI. The nylon-wool-eluted fraction
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TABLE VI.-Adoptive transfer of CP-
stimulated mouse PECt after nylon-wool
columnfractionation
Incidence oftumourst
A
N.W. N.W.
eluted retained
E :T ratio cells cells
1:1 8/8 7/8*
10:1 7/8 3/8***
100:1 7/8 1/8
1000:1 7/8* 0/8
0:1 8/8 8/8
t Harvested on Day 4 after CP treatment.
t 30 days after transfer. Significant reduction in
incidence in bold.
Significant reduction in tumour size as determined
by t test: *P< 0.05; ***P< 0-001.
of PEC showed no capacity to limit
tumour growth; in contrast significant
inhibition oftumour growth was found for
column-retained cells at E: T ratios of
1000: 1,100:1 and 10: 1. In addition, there
was a significant delay in tumour appear-
ance for mice inoculated with CP-stimu-
lated nylon-wool-retained PEC trans-
ferred at 10:1 and 1:1 ratios (P< 0-001 and
P< 0 05 respectively).
DISCUSSION
Thepastdecadehaswitnessednumerous
attempts to suppress tumour growth by
administering immune stimulants. Not-
able successes have been achieved, par-
ticularly following the intralesional in-
jection ofBacillus Calmette Guerin (BCG),
which has caued the regression of large
tumours in experimental animals (Zbar
et al., 1972; Baldwin & Pimm, 1973).
Similarly, CP has also been shown to
possess anti-tumour effects (Castro, 1974;
Ojo, 1979; Milas & Scott, 1978). The
results reported here indicated that CP-
induced resistance to the growth of EL4
cells is restricted to the site ofstimulation,
and in this system at least, no systemic
resistance is apparent. Our results agree
with those reported by Castro (1974) who
demonstrated local resistance to Meth A
tumour cells in mice given i.p. CP. In
contrast to this finding, Ojo (1979) has
shown that CP administered i.p. induced
systemic resistance to transplantation of
the YAC lymphoma line. This tumour is
NK-cell sensitive (Kiessling et al., 1975;
Herberman et al., 1975; Ojo, 1979) while
in vivo-derived EL4 cells are only weakly
susceptible to NK cells (Herberman et al.,
1975); and the Meth A tumour has been
reported to be killed by NC cells but
insensitive to NK cells (Stutman et al.,
1978; Paige et al., 1978). These observa-
tions suggest that CP enhances systematic
NK reactivity, leading to effective in vivo
growth inhibition of NK-sensitive targets.
The results shown here indicate that local
suppression of EL4 cells is not mediated
by NK cells, but by cytotoxic macro-
phages.
Oehler et al. (1978) have reported en-
hanced PEC anti-tumour cytotoxicity in
rats given i.p. CP, which was maintained
for up to 5 weeks; however, the cyto-
toxicity was not fully characterized as
being NK-cell or macrophage mediated.
In the present study we have examined
the induction/augmentation of cyto-
toxicity in vivo by CP, and shown that
two distinct populations of cytotoxic
effector cells are stimulated. The first, a
non-adherent, non-phagocytic cell type
showed selective killing of K562 cells and
was present 2 days after in vivo adminis-
tration of CP. Characterization studies
suggest that these effector cells are NK
cells. The second was glass adherent and
phagocytic, and was present 4 days after
CP administration, showing reactivity to
EL4 target cells from an in vivo transplant
line. The selective reactivity of these
effector cells to different target lines sug-
gests the expression of target receptor
sites specific for different effector-cell
populations.
Although the in vivo role of natural
killer, and other naturally cytotoxic
effector cell mechanisms, is not yet clear,
there is evidence that NK cells may be of
prime importance in immune surveillance
against cancer cells (Kiessling & Wigzell,
1979) and may demonstrate in vivo cyto-
toxicity to blood-borne metastases (Hanna
& Fidler, 1980). The results shown here
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would also suggest that tumour cells
possessing an innate resistance to NK-
mediated cytotoxicity may prove sensitive
to phagocytic cells, which may constitute
an important natural anti-tumour effector
mechanism.
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